Leukocyte extravasation: Chemokine transport and presentation by the endothelium

Blood

Volumn 100, Issue 12, 2002, Pages 3853-3860

  Middleton, Jim ^a,b   Patterson, Angela M ^a   Gardner, Lucy ^a   Schmutz, Caroline ^a   Ashton, Brian A ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GLYCOSAMINOGLYCAN;

BINDING SITE; CARBOHYDRATE ANALYSIS; ENDOTHELIUM CELL; EXTRAVASATION; EXTRAVASCULAR SPACE; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; LEUKOCYTE MIGRATION; MICROVILLUS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; TRANSCYTOSIS;

EID: 0036892646     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.12.3853     Document Type: Review

References (107)

1. Rot A, Hub E, Middleton J, et al. Some aspects of IL-8 pathophysiology, III: Chemokine interaction with endothelial cells. J Leukocyte Biol. 1996;59:39-43.
2. Baggiolini, M. Chemokines in pathology and medicine. J Int Med. 2001;250:91-104.
3. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol. 1999;72:209-253.
4. Carveth HJ, Bohnsack JF, McIntyre TM, Baggiolini M, Prescott SM, Zimmerman GA. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem Biophys Res Commun. 1989;162:387-393.
5. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med. 1990;171:1155-1162.
6. Rot A. Endothelial cell binding of NAP-1/IL-8: Role in neutrophil emigration. Immunol Today. 1992;13:291-294.
7. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today. 1993;14:111-115.
8. Hub E, Rot A. Binding of RANTES, MCP-1, MCP-3 and MIP-1 to cells in human skin. Am J Pathol. 1998;152:749-757.
9. Patterson AM, Chamberlain G, Siddall H, Gardner L, Middleton J. Expression of the Duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium. J Pathol. 2002;197:108-116.
10. Middleton J, Neil S, Wintle J, et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell. 1997;91:385-395.
11. Baekkevold ES, Yamanaka T, Palframan RT, et al. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med. 2001;193:1105-1112.
12. Ebnet K, Kaldjian EP, Anderson AO, Shaw S. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol. 1996;14:155-177.
13. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997;385:640-644.
14. Kuschert GSV, Coulin F, Power CA, et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry. 1999;38:12959-12968.
15. Ihrcke NS, Wrenshall LE, Lindman BJ, Platt JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today. 1993;14:500-505.
16. Goger B, Halden Y, Rek A, et al. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: A model for chemokine regulation at inflammatory sites. Biochemistry. 2002;41:1640-1646.
17. Mbemba E, Slimani H, Atemezem A, Saffar L, Gattegno L. Glycans are involved in RANTES binding to CCR5 positive as well as to CCR5 negative cells. Biochim Biophys Acta. 2001;1510:354-366.
18. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature. 1993;361:79-82.
19. Huber AR, Kunkel SL, Todd RF, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 1991;254:99-102.
20. Gilat D, Hershkoviz R, Mekori YA, Vlodavsky I, Lider, O. Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1β. J Immunol. 1994;153:4899-4906.
21. Tanaka Y, Fuji K, Hubscher S, et al. Heparan sulfate proteoglycan on endothelium efficiently induces integrin-mediated T cell adhesion by immobilizing chemokines in patients with rheumatoid arthritis. Arthritis Rheum. 1998;41:1365-1377.
22. Ali S, Palmer ACV, Fritchley SJ, Maley Y, Kirby JA. Multimedzation of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis. Biochem J. 2001;358:737-745.
23. Hoogewerf AJ, Kuschert GSV, Proudfoot AEI, et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 1997;36:13570-13578.
24. Patel DD, Koopman W, Imai T, Whïchard LP, Yoshie O, Krangel MS. Chemokines have diverse abilities to form solid phase gradients. Clin Immunol. 2001;99:43-52.
25. Graham GJ, Wilkinson PC, Nibbs RJ, et al. Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1 alpha by mutagenesis of the proteoglycan binding site. EMBO J. 1996;15:6506-6515.
26. Koopman W, Ediriwickrema C, Krangel MS. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1. J Immunol. 1999;163:2120-2127.
27. Ali S, Palmer ACV, Banerjee B, Fritchley SJ, Kirby JA. Examination of the function of RANTES, MIP-1α, and MIP-1β following interaction with heparin-like glycosaminoglycans. J Biol Chem. 2000;275:11721-11727.
28. Maione TE, Gray GS, Hunt AJ, Sharpe RJ. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 1991;51:2077-2083.
29. Webb LM, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci U S A. 1993;90:7158-7162.
30. Chakravarty L, Rogers L, Quach T, Breckenridge S, Kolattukudy PE. Lysine 58 and histidine 66 at the C-terminal α-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J Biol Chem. 1998;273:29641-29647.
31. Kuschert GSV, Hoogewerf AJ, Proudfoot AEI, et al. Identification of a glycosaminoglycan binding site on human interleukin-8. Biochemistry. 1998;37:11193-11201.
32. Luo J, Luo Z, Zhou N, Hall JW, Huang Z. Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide. Biochem Biophys Res Commun. 1999;264:42-47.
33. Mayo KH, Ilyina E, Roongta V, et al. Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: Arginine residues are crucial for binding. Biochem J. 1995;312:357-365.
34. Amara A, Lorthioir O, Valenzuela A, et al. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem. 1999;274:23916-32925.
35. Proudfoot AEI, Fritchley S, Borlat F, et al. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem. 2001;276:10620-10626.
36. Koopman W, Krangel MS. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1α. J Biol Chem. 1997;272:10103-10109.
37. Spillman D, Witt D, Lindahl U. Defining the interleukin-8 binding domain of heparan sulfate. J Biol Chem. 1998;273:15487-15493.
38. Stringer SE, Gallagher JT. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J Biol Chem. 1997;272:20508-20514.
39. Witt DP, Lander AD. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol. 1994;4:394-400.
40. Luster AD, Greenberg SH, Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med. 1995;182:219-231.
41. Lowe-Krentz LJ, Joyce JG. Venous and aortic porcine endothelial cells cultured under standardized conditions synthesize heparan sulfate chains which differ in charge. Anal Biochem. 1991;193:155-163.
42. Netelenbos T, Drager AM, van het Hot B, et al. Differences in suifation patterns of heparan sulfate derived from human bone marrow and umbilical vein endothelial cells. Exp Hematol. 2001;29:884-893.
43. Kusche-Gullberg M, Eriksson I, Sandback Pikas D, Kjellen L. Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes. J Biol Chem. 1998;273:11902-11907.
44. Wight TN. Proteoglycans in pathological conditions: Atherosclerosis. Fed Proc. 1985;44:381-385.
45. Mertens G, Cassiman J-J, Van den Berghe, Vermylen J, David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. J Biol Chem. 1992;267:20435-20443.
46. Oohira A, Wight TN, Bornstein P. Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J Biol Chem. 1983;258:2014-2021.
47. Inoue S, Osmond DG. Basement membrane of mouse bone marrow sinusoids shows distinctive structure and proteoglycan composition: A high resolution ultrastructural study. Anat Rec. 2001;264:294-304.
48. Marquezini MV, Strunz CMC, Dallan LAO, Toledo OMS. Glycosaminoglycan distribution in atherosclerotic saphenous vein grafts. Cardiology. 1995;86:143-146.
49. Murch SH, Macdonald TT, Walker-Smith JA, Levin M, Lionetti P, Klein NJ. Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet. 1993;341:711-714.
50. Wasty F, Alavi MZ, Moore S. Distribution of glycosaminoglycans in the intima of human aortas: Changes in atherosclerosis and diabetes mellitus. Diabetologia. 1993;36:316-322.
51. Chaudhuri A, Nielsen S, Elkjaer M, Zbrzezna V, Fang F, Pogo AO. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood. 1997;89:701-712.
52. Hadley TJ, Peiper SC. From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen. Blood. 1997;89:3077-3091.
53. Neote K, Mak JY, Kolakowski LF, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: Identity with the red blood cell chemokine receptor. Blood. 1994;84:44-52.
54. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem. 1993;268:12247-12249.
55. Szabo M, Soo KS, Zlotnik A, Schall TJ. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem. 1995;270:25348-25351.
56. Peiper SC, Wang Z, Neote K, Martin AW, Showell H, Conklyn MJ. The Duffy antigen/receptor for chemokines (DARC) is expressed in the endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med. 1995;181:1311-1317.
57. Dawson TC, Lentsch AB, Wang Z, et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood. 2000;96:1681-1684.
58. Luo H, Chaudhuri A, Zbrzezna V, He Y, Pogo AO. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol. 2000;20:3097-3101.
59. Hesselgesser J, Chitnis CE, Miller LH, et al. A mutant of melanoma growth stimulating activity does not activate neutrophils but blocks erythrocyte invasion by malaria. J Biol Chem. 1995;270:11472-11476.
60. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest. 1991;88:1362-1369.
61. Du J, Luan J, Liu H, et al. Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress. J Leukoc Biol. 2002;71:141-153.
62. Feil C, Augustin HG. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Comm. 1998;247:38-45.
63. Weber KS, Nelson PJ, Grone HJ, Weber C. Expression of CCR2 by endothelial cells: Implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterloscier Thromb Vasc Biol. 1999;19:2085-2093.
64. Addison CL, Daniel TO, Burdick MD, et al. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol. 2000;165:5269-5277.
65. Bernadini G, Spinetti G, Ribatti D, et al. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood. 2000;96:4039-4045.
66. Romagnani P, Annunziatd F, Lasagni L, et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest. 2001;107:53-63.
67. Petzelbauer P, Watson CA, Pfau SE, Pober JS. IL-8 and angiogenesis: Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine. 1995;7:267-272.
68. Schonbeck U, Brandt E, Petersen F, Flad H-D, Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol. 1995;154:2375-2383.
69. Salcedo R, Resau JH, Halverson D, et al. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J. 2000;14:2055-2064.
70. Nanney LB, Mueller SG, Bueno R, Peiper SC, Richmond A. Distributions of melanoma growth stimulatory activity or growth-regulated gene and the interleukin-8 receptor B in human wound repair. Am J Pathol. 1995;147:1248-1260.
71. Rampart M, Van Damme J, Zonnekeyn L, Herman AG. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol. 1989;135:21-25.
72. Biffl WL, Moore EE, Moore FA, Carl V, Franciose RJ, Banerjee A. Interleukin-8 increases endotheilar permeability independent of neutrophils. J Trauma. 1995;39:98-103.
73. Fukumoto T, Matsukawa A, Yoshimura T. IL-8 is an essential mediator of the increased delayed-phase vascular permeability in LPS-induced rabbit pleurisy. J Leukocyte Biol. 1998;63:584-590.
74. Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL, Butcher EC. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell. 1991;66:921-933.
75. Erlandsen SL, Hasslen SR, Nelson RD. Detection and spatial distribution of the β2 integrin (Mac-1) and L-selectin (LECAM-1) adherence receptors on human neutrophils by high-resolution field emission SEM. J Histochem Cytochem. 1993;41:327-333.
76. Berlin C, Bargatze RF, Campbell JJ, et al. α4 integrins mediate lymphocyte attachment and rolling under physiological flow. Cell. 1995;80:413-422.
77. Moore KL, Patel KD, Bruehl RE, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol. 1995;128:661-671.
78. Pavalko, FM, Walker DM, Graham L, Goheen M, Doerschuk CM, Kansas GS. The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins α-actinin: Receptor positioning in microvilli does not require interaction with α-actinin. J Cell Biol. 1995;129:1155-1164.
79. Bruehl, RE, Moore KL, Lorant DE, et al. Leukocyte activation induces surface redistribution of P-selectin glycoprotein ligand-1. J Leukocyte Biol. 1997;61:489-499.
80. Girard J-P, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzag P, Amalric F. Heterogeneity of endothelial cells: The specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol. 1999;155:2043-2055.
81. Fina I, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417-2426.
82. Delia D, Lampugnani MG, Resnati M, et al. CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood. 1993;81:1001-1008.
83. von Andrian UH, Hasslen SR, Nelson RD, Erlandsen SL, Butcher EC. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell. 1995;82:989-999.
84. Stein JV, Cheng G, Stockton BM, Fors BP, Butcher EC, von Andrian UH. L-selectin-mediated leukocyte adhesion in vivo: Microvillous distribution determines tethering efficiency, but not rolling velocity. J Exp Med. 1999;189:37-49.
85. Finger EB, Bruehl RE, Bainton DF, Springer TA. A differential role for cell shape in neutrophil tethering and rolling on endothelial selectins under flow. J Immunol. 1996;157:5085-5096.
86. Singer I, Scott S, Kawka DW, et al. CCR5, CXCR4 and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol. 2001;75:3779-3790.
87. Abitorabi MA, Pachynski RK, Ferrando RE, Tidswell M, Erle DJ. Presentation of integrins on leukocyte microvilli: A role for the extracellular domain in determining membrane localization. J Cell Biol. 1997;139:563-571.
88. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC. Two-step model of leukocyte-endothelial interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci U S A. 1991;88:7538-7542.
89. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiological flow rates: Distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859-873.
90. von Andrian UH, Hansell P, Chambers JD, et al. L-selectin function is required for β2-integrin mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol. 1992;263:H1034-H1044.
91. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb. 1998;18:842-851.
92. Detmar M, Tenorio S, Hettmannsperger U, Ruszezak Z, Orfanos CE. Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol. 1992;98:147-153.
93. Lichtman MA, Weed RI. Electrophoretic mobility and N-acetyl neuraminic acid content of human normal and leukemic lymphocytes and granulocytes. Blood. 1970;35:12-22.
94. Pelikan P, Gimbrone MA, Coltran RS. Distribution and movement of anionic cell surface sites in cultured human vascular endothelial cells. Atherosclerosis. 1979;32:69-80.
95. Hub E, Middleton J, Rot A. Mechanism of chemokine-induced leukocyte adhesion and emigration. In: Horuk R, ed. Chemoattractant Ligands and Their Receptors. Boca Raton, FL: CRC Press;1996:301-324.
96. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med. 1998;187:903-915.
97. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF. The vesiculo-vacuolar organelle (VVO): A distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukocyte Biol. 1996;59:100-115.
98. Feng D, Nagy JA, Hipp J, Pyne K, Dvorak HF, Dvorak AM. Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea-pig, mouse and rat: Many are transcellular pores. J Physiol. 1997;504:747-761.
99. Hoshi O, Ushiki T. Scanning electron microscopic studies on the route of neutrophil extravasation in the mouse after exposure to the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP). Arch Histol Cytol. 1999;62:253-260.
100. Marchesi VT, Florey HW. Electron micrographic observations on the emigration of leukocytes. Q J Exp Physiol. 1960;45:343-347.
101. Faustmann PM, Dermietzel R. Extravasation of polymorphonuclear leukocytes from the cerebral microvasculature. Cell Tissue Res. 1985;242:399-407.
102. Schubert C, Christophers E, Swensson O, Isei T. Transendothelial cell diapedesis of neutrophils in inflamed human skin. Arch Dermatol Res. 1989;281:475-481.
103. Marchesi VT. The site of leukocyte emigration during inflammation. Q J Exp Physiol. 1961;46:115-206.
104. Thureson-Klein A, Hedqvist P, Lindbom L. Leukocyte diapedesis and plasma extravasation after leukotriene B4: Lack of structural injury to the endothelium. Tissue Cell. 1986;18:1-12.
105. Burns AR, Bowden RA, MacDonell SD, et al. Analysis of tight junctions during neutrophil transendothelial migration. J Cell Sci. 2000;113:45-57.
106. Swensson O, Schubert C, Christophers E, Schroder JM. Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: A light- and electron microscopic study. J Invest Dermatol. 1991;96:682-689.
107. Zlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity. 2000;12:121-127.